Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties
Yıl: 2019 Cilt: 23 Sayı: 5 Sayfa Aralığı: 777 - 784 Metin Dili: İngilizce DOI: 10.35333/jrp.2019.24 İndeks Tarihi: 20-06-2020
Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties
Öz: A folkloric herbal extract of five plants (Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica), is emerging as a promising hemostatic agent with strong immunological, antiinflammatory, antimicrobial, anti-mutagenic, and antioxidant properties. Though its use as a hemostatic agent in the various general surgical procedure involving gastrointestinal, variceal, presacral bleeding, burns, and epistaxis, etc. is established, very little data comprehensively highlights the mechanisms and clinical application of this potential folkloric combination. The present paper aims to highlight the mechanism of this unique herbal combination with the aim to lay the foundation for further research using this novel hemostatic agent.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Chen C, Yang FQ, Zhang Q, Wang FQ, Hu YJ, Xia ZN. Natural Products for Antithrombosis. Evid Based Complement Alternat Med. 2015; 2015: 876426. [CrossRef]
- Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, Firat HC. Hemostatic actions of the folkloric medical plant extract Ankaferd Blood Stopper. J Int Med Res. 2008; 36: 163-170. [CrossRef]
- Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev. 2010; 15: 329-336.
- Baykul T, Alanoglu EG, Kocer G. Use of Ankaferd Blood Stopper as a hemostatic agent: A clinical experience. J Contemp Dent Pract. 2010; 11(1): E088–E094.
- Aktas A, Nuray ER, Kırıs S, Koseoglu OT, Haznedaroglu IC. The efficiency of Ankaferd Blood Stopper during the dental surgery in hemorrhagic. Diathesis: Case Series. Int J Hematol Oncol. 2010; 20: 1–5. [CrossRef]
- Balcik OS, Koroglu M, Cipil H, Kaftan O, Maral S, Gurel A, et al. A placebo controlled, randomized, double-blinded, cross-over phase 1 clinical study to demonstrate safety of Ankaferd Blood Stopper topical usage in healthy volunteers. Int J Lab Hem. 2010; 32: 126-127. [CrossRef]
- Bilgili H, Captug O, Kosar A, Kurt M, Kekilli M, Shorbagi A, Kurt OK, Ozdemir O, Goker H, Haznedaroglu IC. Oral systemic administration of Ankaferd blood stopper has no short-term toxicity in an in vivo rabbit experimental model. Clin Appl Thromb Hemost. 2010; 16(5): 533-536. [CrossRef]
- Tasdelen Fisgin N, Tanriverdi Cayci Y, Coban AY, Ozatli D, Tanyel E, Durupinar B, Tulek N. Antimicrobial activity of plant extract Ankaferd Blood Stopper. Fitoterapia. 2009; 80(1): 48-50. [CrossRef]
- Cinar C, Odabas ME, Akca G, Isik B. Antibacterial effect of a new hemostatic agent on oral microorganisms. J Clin Exp Dent. 2012; 4(3): e151–e155. [CrossRef]
- Aysan E, Bektas H, Ersoz F, Sari S, Kaygusuz A, Huq GE. Ability of the Ankaferd Blood Stopper® to prevent parenchymal bleeding in an experimental hepatic trauma model. Int J Clin Exp Med 2010; 3: 186-190.
- Huri E, Haznedaroglu IC, Akgul T, Astarci M, Ustun H, Germiyanoulu C. Biphasic effects of Ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage. Saudi Med J. 2010; 30: 864-868.
- Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy. 2008; 40(2): E262. [CrossRef]
- Kurt M, Akdogan M, Onal IK, Kekilli M, Arhan M, Shorbagi A, Aksu S, Kurt OK, Haznedaroglu IC. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis. 2010; 42(3): 196-199 [CrossRef]
- Kurt M, Onal I, Akdogan M, Kekilli M, Arhan M, Sayilir A, Oztas E, Haznedaroglu I. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures. Can J Gastroenterol. 2010; 24: 380–384. [CrossRef]
- Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. A new candidate as a hemostatic agent for difficult situations during variceal bleeding: Ankaferd blood stopper. Saudi J Gastroenterol. 2011; 17(2): 145-148. [CrossRef]
- Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol. 2009; 73(12): 1742-1745. [CrossRef]
- Teker AM, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol. 2010; 267: 1377-1381. [CrossRef]
- Karakaya K, Ucan HB, Tascilar O, Emre AU, Cakmak GK, Irkorucu O, Ankarali H, Comert M. Evaluation of a new hemostatic agent Ankaferd Blood Stopper in experimental liver laceration. J Invest Surg. 2009; 22(3): 201-206. [CrossRef]
- Haznedaroglu IC. Molecular basis of the pleiotropic effects of Ankaferd Blood Stopper. IUBMB Life. 2009; 61(3): 290.
- Haznedaroglu BZ1, Beyazit Y, Walker SL, Haznedaroglu IC. Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat. Crit Rev Onco Hematol. 2012; 83(1): 21-34. [CrossRef]
- Al B, Yildirim C, Cavdar M, Zengin S, Buyukaslan H, Kalender ME. Effectiveness of Ankaferd blood stopper in the topical control of active bleeding due to cutaneous-subcutaneous incisions. Saudi Med J. 2009; 30(12): 1520-1525.
- Akar N, Demiralp DO, Haznedaroglu IC, Goker H. Functional Proteomics of Ankaferd Blood Stopper. Blood. 2008; 112: 4103.
- Haznedaroglu BZ, Haznedaroglu IC, Walker SL, Bilgili H, Goker H, Kosar A. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb Hemost. 2010; 16(4): 446–453. [CrossRef]
- Yılmaz E, Gulec S, Haznedaroglu IC, Akar N. Effects of Ankaferd on HUVEC transcription factors and erythrocyte protein profile. Turk J Hematol. 2011; 28(4): 276-285. [CrossRef]
- Cipil HS, Kosar A, Kaya A, Uz B, Haznedaroglu IC, Goker H, et al. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin. Clin Appl Thromb Hemost. 2009; 15(3): 270-276. [CrossRef]
- Kurt M, Disibeyaz S, Akdogan M, Sasmaz N, Aksu S, Haznedaroglu IC. Endoscopic application of ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: A case report. Am J Gastroenterol. 2008; 103(8): 2156-2158.
- Ibis M, Kurt M, Onal IK, Haznedaroglu IC. Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd blood stopper. J Altern Complement Med. 2008; 14(9): 1073-1074. [CrossRef]
- Kelles M, Kalcioglu MT, Samdanci E, Selimoglu E, Iraz M, Miman MC, Haznedaroglu IC. Ankaferd blood stopper is more effective than adrenaline plus lidocaine and gelatin foam in the treatment of epistaxis in rabbits. Curr Ther Res Clin Exp. 2011; 72(5): 185-194. [CrossRef]
- Kazancıoglu HO, Cakır O, Ak G, Zülfikar B. The effectiveness of a new hemostatic agent (ankaferd blood stopper) for the control of bleeding following tooth extraction in hemophilia: A controlled clinical trial. Turk J Haematol. 2013; 30(1): 19–24. [CrossRef]
- Cakarer S, Eyupoglu E, Ozcamur GC, Kuseoglu GB, Berberoglu KH, Keskin C. Evaluation of the hemostatic effects of Ankaferd Blood Stopper during dental extractions in patients on antithrombotic therapy. Clin Appl Thromb Hemost. 2013; 19(1): 96–99. [CrossRef]
- Bilgili H, Kosar A, Kurt M, Onal IK, Goker H, Captug O, Shorbagi A, Turgut M, Kekilli M, Kurt OK, Kirazli S, Aksu S, Haznedaroglu IC. Hemostatic effects of Ankaferd in a swine bleeding model. Med Princ Pract. 2009; 18(3): 165-169. [CrossRef]
- Kosar A, Cipil HS, Kaya A, Uz B, Haznedaroglu IC, Goker H, Ozdemir O, Ercetin S, Kirazli S, Firat HC. The efficacy of Ankaferd Blood Stopper in antithrombotic drug induced primary and secondary hemostatic abnormalities of a rat bleeding model. Blood Coagul Fibrinolysis. 2009; 20: 185-190. [CrossRef]
- Oner AF, Doğan M, Kaya A, Sal E, Bektaş MS, Yesilmen O, Ayhan H, Acikgoz M. New coagulant agent (ankaferd blood stopper) for open hemorrhages in hemophilia with inhibitor. Clin Appl Thromb Hemost. 2010; 16(6): 705-707. [CrossRef]
- Zulfikar OB, Emiroglu HH, Kebudi R. Nasogastric application of topical Ankaferd Blood Stopper for bleeding from primary esophageal adenocarcinoma in a child with disseminated intravascular coagulation. Dig Liver Dis. 2011; 43(3): 247-248. [CrossRef]
- Tek M, Akkas I, Toptas O, Ozan F, Sener I, Bereket C. Effects of the topical hemostatic agent Ankaferd Blood Stopper on the incidence of alveolar osteitis after surgical removal of an impacted mandibular third molar. Niger J Clin Pract. 2014; 17(1): 75-80. [CrossRef]
- Pellati D , Fiore C , Armanini D , et al. In vitro effect of glycyrrhetinic acid on the growth of clinical isolates of Candida albicans. Phytother Res. 2009; 23: 572-574. [CrossRef]
- Motsei ML , Lindsey KL , van Staden J , Jäger AK. Screening of traditionally used South African plants for antifungal activity against Candida albicans. J Ethnopharmacol. 2003; 86: 235-241. [CrossRef]
- Arslan S, Ertaş H, Zorba YO. Influence of Ankaferd Blood Stopper on shear bond strength of bonding systems. Dent Mater J. 2012; 31(2): 226-31. [CrossRef]
- Simsek HO, Teuzeum MS, Baykul T, Geurer IE, Bassorgun CI. Experimental investigation of the effects of a blood stopper agent (Ankaferd Blood Stopper) on bone surfaces. Turk J Haematol. 2013; 30(3): 177–183. [CrossRef]
- Trakyali G, Oztoprak MO. Plant extract ankaferd blood stopper effect on bond strength. Angle Orthod. 2010; 80(3): 570-574. [CrossRef]
- Ozmen B, Bayrak S. Comparative evaluation of ankaferd blood stopper, ferric sulfate, and formocresol as pulpotomy agent in primary teeth: A clinical study. Niger J Clin Pract. 2017; 20(7): 832-838. [CrossRef]
- Odabaş ME, Çinar C, Tulunoǧlu O, Işik B. A new haemostatic agent's effect on the success of calcium hydroxide pulpotomy in primary molars. Pediatr Dent. 2011; 33(7): 529–534.
- Yaman E, Georken F, Pinar EA, Sepet E, Aytepe Z. Effects of folk medicinal plant extract Ankaferd Blood Stopper in vital primary molar pulpotomy. Eur Arch Paediatr Dent. 2012; 13: 197–202. [CrossRef]
- Koyuturk AE, Tunç ES, Bayrak S, Ayas B, Ozmen B, Korkmaz A. Histological evaluation of Ankaferd blood stopper, ferric sulfate and formocresol as pulpotomy agents in rat molars. J Pediatr Dent. 2013; 1(2): 32-36.
- Sheela ML, Ramakrishna MK, Salimath BP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol. 2006; 6(3): 494–498. [CrossRef]
- Karabıyık A, Yılmaz E, Gülec S, Haznedaroglu I, Akar N. The dual diverse dynamic reversible effects of Ankaferd Blood Stopper on EPCR and PAI-1 inside vascular endothelial cells with and without LPS challenge. Turk J Hematol. 2012; 29: 361-366. [CrossRef]
- Ciftci S, Keskin F, Keceli Ozcan S, Erdem MA, Cankaya B, Bingol R, Kasapoglu C. In Vitro Antifungal Activity of Ankaferd Blood Stopper against Candida albicans. Curr Ther Res Clin Exp. 2011; 72(3): 120-126. [CrossRef]
- Lee SJ, Umano K, Shibamoto T. Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chem. 2007; 91(1): 131-137. [CrossRef]
- Fatima A, Gupta VK, Luqman S, Negi AS, Kumar JK, Shanker K, Saikia D, Srivastava S, Darokar MP, Khanuja SP.. Antifungal activity of Glycyrrhiza glabra extracts and its active constituent glabridin. Phytother Res. 2009; 23(8): 1190–1193. [CrossRef]
- Bulut E, Baş B, Altunkaynak BZ, Bekçioğlu B, Erdem Koç G, Gönülol E, Önger ME, Kaplan S. Efficacy of Ankaferd Blood Stopper on bone healing in diabetic rats: a stereological and histopathological study. Biotech Histochem. 2014; 89(7): 535-543. [CrossRef]
- Pamuk F, Cetinkaya BO, Keles GC, Balli U, Koyuncuoglu CZ, Cintan S, Kantarci A. Ankaferd blood stopper enhances healing after osseous grafting in patients with intrabony periodontal defects. J Periodont Res. 2016; 51: 540–547. [CrossRef]
- Coban YK, Ozerol E, Tanber K, Erbatur S, Aytekin AH, Fırat C. Hemeostatic efficacy of Ankaferd after excision of full thickness burns: a comparative experimental study in rats. Surgical Science 2011; 2(1):16-21. [CrossRef]
- Isler SC, Demircan S, Cakarer S, Cebi Z, Keskin C, Soluk M. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci. 2010; 18(4): 409–414. [CrossRef]
- Göker H, Çetinkaya D, Kılıç E, Haznedaroğlu IC, Kirazlı S, Fırat H. Anti-cancer activity of Ankaferd blood stopper on osteosarcoma (SAOS-2) cell lines in vitro. In: Haznedaroğlu I.C. GH, Özdemir O, Koşar A, Fırat H, editors. Ankaferd: Scientific perspectives and basic-clinical data. Naviga Publications İstanbul, Turkey 2008: 109.
- Göker H, Kılıc E, Çetinkaya D, Haznedaroğlu IC, Kirazlı S, Fırat H. Anti-cancer activity of Ankaferd on human colon cancer (CACO-2) in vitro. In: Haznedaroğlu IC, Göker H, Özdemir O, Koşar A, Fırat H editors. Ankaferd: Scientific perspectives and basic-clinical Data. Naviga Publications İstanbul, Turkey 2008: 108.
- Turk S, Malkan UY, Ghasemi M, Hocaoglu H, Mutlu D, Gunes G, Aksu S, Haznedaroglu IC. Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines. SAGE Open Med. 2017; 5: 2050312116689519. [CrossRef]
- Akalin I, Okur FV, Haznedaroglu IC, Sayinalp N, Aksu S, Buyukasik Y, Goker H. Acute in vitro effects of ABS (Ankaferd hemostat) on the lymphoid neoplastic cells (B-CLL and RAJI tumor cell lines). UHOD. 2014; 24(4): 253– 259. [CrossRef]
- Mumcuoglu M, Akin DF, Ezer U, Akar N. Ankaferd Blood Stopper induces apoptosis and regulates PAR1 and EPCR expression in human leukemia cells. Egypt J Med Human Gen. 2015; 16(1): 19–27. [CrossRef]
| APA | CHOPRA A, Sivaraman K (2019). Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. , 777 - 784. 10.35333/jrp.2019.24 |
| Chicago | CHOPRA ADITI,Sivaraman Karthik Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. (2019): 777 - 784. 10.35333/jrp.2019.24 |
| MLA | CHOPRA ADITI,Sivaraman Karthik Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. , 2019, ss.777 - 784. 10.35333/jrp.2019.24 |
| AMA | CHOPRA A,Sivaraman K Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. . 2019; 777 - 784. 10.35333/jrp.2019.24 |
| Vancouver | CHOPRA A,Sivaraman K Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. . 2019; 777 - 784. 10.35333/jrp.2019.24 |
| IEEE | CHOPRA A,Sivaraman K "Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties." , ss.777 - 784, 2019. 10.35333/jrp.2019.24 |
| ISNAD | CHOPRA, ADITI - Sivaraman, Karthik. "Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties". (2019), 777-784. https://doi.org/10.35333/jrp.2019.24 |
| APA | CHOPRA A, Sivaraman K (2019). Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. Journal of research in pharmacy (online), 23(5), 777 - 784. 10.35333/jrp.2019.24 |
| Chicago | CHOPRA ADITI,Sivaraman Karthik Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. Journal of research in pharmacy (online) 23, no.5 (2019): 777 - 784. 10.35333/jrp.2019.24 |
| MLA | CHOPRA ADITI,Sivaraman Karthik Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. Journal of research in pharmacy (online), vol.23, no.5, 2019, ss.777 - 784. 10.35333/jrp.2019.24 |
| AMA | CHOPRA A,Sivaraman K Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. Journal of research in pharmacy (online). 2019; 23(5): 777 - 784. 10.35333/jrp.2019.24 |
| Vancouver | CHOPRA A,Sivaraman K Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties. Journal of research in pharmacy (online). 2019; 23(5): 777 - 784. 10.35333/jrp.2019.24 |
| IEEE | CHOPRA A,Sivaraman K "Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties." Journal of research in pharmacy (online), 23, ss.777 - 784, 2019. 10.35333/jrp.2019.24 |
| ISNAD | CHOPRA, ADITI - Sivaraman, Karthik. "Ankaferd blood stopper: A novel hemostatic agent with unique antimicrobial, antineoplastic and regenerative properties". Journal of research in pharmacy (online) 23/5 (2019), 777-784. https://doi.org/10.35333/jrp.2019.24 |
